| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |